Regulatory News
Wednesday, April 27, 2016
BRIEF-Immune Therapeutics says NAFDAC approves Lodonal
* NAFDAC approved lodonal as over counter, non-toxic adjunct
therapy in treatment of HIV/Aids and immune system regulator
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom; +1...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment